Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria

BACKGROUND: Omalizumab is shown to be effective in the treatment of chronic spontaneous urticaria (CSU), a disease with high personal and social impact. Sex differences in CSU are recognized with women more frequently affected. Scarce is the knowledge about response to omalizumab between sex groups....

Descripción completa

Detalles Bibliográficos
Autores principales: Sirufo, Maria Maddalena, Bassino, Enrica Maria, De Pietro, Francesca, Ginaldi, Lia, De Martinis, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855371/
https://www.ncbi.nlm.nih.gov/pubmed/35170369
http://dx.doi.org/10.1177/20587384211065870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855371/
https://www.ncbi.nlm.nih.gov/pubmed/35170369
http://dx.doi.org/10.1177/20587384211065870

Ejemplares similares